标题
Deep Response in Multiple Myeloma: A Critical Review
作者
关键词
-
出版物
Biomed Research International
Volume 2015, Issue -, Pages 1-7
出版商
Hindawi Limited
发表日期
2015-12-11
DOI
10.1155/2015/832049
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality
- (2015) J. Martinez-Lopez et al. BLOOD
- New criteria for response assessment: role of minimal residual disease in multiple myeloma
- (2015) B. Paiva et al. BLOOD
- Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction
- (2015) A. C. Rawstron et al. BLOOD
- Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival
- (2015) Renji Reghunathan et al. Oncotarget
- Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
- (2014) J. Martinez-Lopez et al. BLOOD
- Curing myeloma at last: defining criteria and providing the evidence
- (2014) B. Barlogie et al. BLOOD
- Quality assessment program for EuroFlow protocols: Summary results of four-year (2010-2013) quality assurance rounds
- (2014) Tomas Kalina et al. CYTOMETRY PART A
- The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma
- (2014) B. Paiva et al. HAEMATOLOGICA
- Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival
- (2014) S Ferrero et al. LEUKEMIA
- The utility of newer imaging techniques as predictors of clinical outcomes in multiple myeloma
- (2014) Annamaria Brioli et al. Expert Review of Hematology
- Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile
- (2013) B. Paiva et al. BLOOD
- Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3
- (2013) S. Z. Usmani et al. BLOOD
- Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study
- (2013) Joaquin Martinez-Lopez et al. BRITISH JOURNAL OF HAEMATOLOGY
- Establishment and Validation of Analytical Reference Panels for the Standardization of Quantitative BCR-ABL1 Measurements on the International Scale
- (2013) H. E. White et al. CLINICAL CHEMISTRY
- Importance of Achieving Stringent Complete Response After Autologous Stem-Cell Transplantation in Multiple Myeloma
- (2013) Prashant Kapoor et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
- (2013) Andy C. Rawstron et al. JOURNAL OF CLINICAL ONCOLOGY
- Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry
- (2013) N Puig et al. LEUKEMIA
- Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
- (2013) M Ladetto et al. LEUKEMIA
- Has MRD monitoring superseded other prognostic factors in adult ALL?
- (2012) M. Bruggemann et al. BLOOD
- Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
- (2012) L. Rosinol et al. BLOOD
- Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma
- (2012) Jesús F. San Miguel et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients
- (2012) H Ludwig et al. LEUKEMIA
- Multiple Myeloma in Serologic Complete Remission after Autologous Stem Cell Transplantation: Impact of Bone Marrow Plasma Cell Assessment by Conventional Morphology on Disease Progression
- (2011) Carlos Fernández de Larrea et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-term prognostic significance of response in multiple myeloma after stem cell transplantation
- (2011) J. Martinez-Lopez et al. BLOOD
- High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
- (2011) B. Paiva et al. BLOOD
- Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
- (2011) S. V. Rajkumar et al. BLOOD
- International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
- (2011) M. Cavo et al. BLOOD
- Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
- (2011) F. Gay et al. BLOOD
- Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
- (2011) E. Zamagni et al. BLOOD
- Roadmap for Harmonization of Clinical Laboratory Measurement Procedures
- (2011) W. Greg Miller et al. CLINICAL CHEMISTRY
- Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma
- (2011) Bruno Paiva et al. JOURNAL OF CLINICAL ONCOLOGY
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- Assessment of minimal residual disease in acute myeloid leukemia
- (2010) David Grimwade et al. CURRENT OPINION IN ONCOLOGY
- Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders
- (2010) Bruno Paiva et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
- (2010) Marco Ladetto et al. JOURNAL OF CLINICAL ONCOLOGY
- The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma
- (2009) C. E. Chee et al. BLOOD
- The relationship between the serum free light chain assay and serum immunofixation electrophoresis, and the definition of concordant and discordant free light chain ratios
- (2009) S. Singhal et al. BLOOD
- Sensitivity of serum free light chain measurement of residual disease in multiple myeloma patients
- (2009) G. P. Mead et al. BLOOD
- Serum Free Light Chain Ratio, Total / Ratio, and Immunofixation Results Are Not Prognostic Factors after Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
- (2009) M. M. Giarin et al. CLINICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started